95437 ⎘
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups - , , or in which the condensed system contains two hetero rings; Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Sub-classes:PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY
#2KCC2 POTENTIATORS AND USES THEREOF
#3CB1R RECEPTOR BLOCKERS WITH ACYCLIC BACKBONES
#4PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER
#5NEW CRYSTAL FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#6NEW CRYSTAL FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#7HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE
#8AZACYCLOALKYL CARBONYL CYCLIC AMINE COMPOUND
#9HERBICIDAL PYRIDONE DERIVATIVES
#10THERAPEUTIC ALKALOID COMPOUNDS
#11Compound containing structure of a heteroaromatic ring, pharmaceutical composition thereof and application thereof
#12Antiviral Heterocyclic Compounds
#13MACROCYCLIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF PREPARING AND USING THE SAME
#14PROCESS OF PREPARING (1R, 4R, 5S)-4-(2-CHLOROETHYL)-1-((S)-((S)-CYCLOHEX-2-EN-1-YL)(HYDROXY)METHYL)-5-METHYL-6-OXA-2-AZABICYCLO[3.2.0]HEPTANE-3,7-DIONE(SALINOSPORAMIDE A; MARIZOMIB)
#15PHENYLPIPERIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN
#16TAAR1 AND SEROTONIN MODULATORS, AND PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
#17PERIPHERALLY RESTRICTED CB1 RECEPTOR BLOCKERS AND USES THEREOF
#18MACROCYCLE COMPLEMENT FACTOR B INHIBITORS
#19FUSED RING COMPOUND AS WEE-1 INHIBITOR
#207-OXA-3,4-DIAZABICYCLO[4.1.0]HEPT-4-EN-2-ONE COMPOUND AND HERBICIDE
#21Modulators of complex I
#22Electrolyte solution for lithium secondary battery and lithium secondary battery including the same
#23PROCESS FOR THE PREPARATION OF ASENAPINE IN THE FORM OF ITS FREE BASE
#24Macrocyclic compounds and compositions, and methods of preparing and using the same
#25INDAZOLE-FUSED CYCLIC COMPOUND
#26FUSED RING COMPOUND AND APPLICATION THEREOF IN MEDICINE
#27AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS
#28Method for preparation of Asenapine
#29Antiviral heterocyclic compounds
#30AMORPHOUS FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#31Tricyclic compounds as histone methyltransferase inhibitors
#32CRYSTALLINE FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#33Antiviral heterocyclic compounds
#34Bicyclic lactams and methods of use thereof
#35Oxepinopyrazole derivatives as inhibitors of P13-kinase activity
#367-OXA-3,4-DIAZABICYCLO [4.1.0] HEPT-4-EN-2-ONE COMPOUND AND HERBICIDE
#37N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS
#38Protease inhibitors, preparation, and uses thereof
#39SUBSTITUTED OXOPYRIDINE DERIVATIVES
#40CB1R RECEPTOR BLOCKERS WITH ACYCLIC BACKBONES
#41Conjugated triene compound, and preparation and application thereof
#42N-substituted indoles and other heterocycles for treating brain disorders
#43AZIRIDINE CONTAINING EPOTHILONE ANALOGS, METHODS OF SYNTHESIS, METHODS OF TREATMENT, AND DRUG CONJUGATES
#44AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS
#45Modulators of complex I
#46Method for preparation of Asenapine
#47MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE
#48Nitrogenous tricyclic compounds and uses thereof in medicine
#49Substituted thiohydantoin derivatives as androgen receptor antagonists
#50Method for producing optically active substance, optically active substance, method for producing chiral molecule, and chiral molecule
#51Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereof
#5216-methyl-oxacyclohexadecan-2-one and 16-methyl-azacyclohexadecan-2-one derivatives as antimicrobial agents
#53MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE
#54Substituted oxepines
#55Salinosporamides and methods of use thereof
#56Nitrogen-containing tricyclic compounds and uses thereof in medicine
#57Tricyclic compounds and compositions as kinase inhibitors
#58MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF
#59Tricyclic PI3K inhibitor compounds and methods of use
#60Substituted thiohydantoin derivatives as androgen receptor antagonists
#61Heterocyclic compounds and uses thereof
#62Modified cytotoxins and their therapeutic use
#63Heterocyclic thiosemicarbazone derivatives and their therapeutical applications
#64Tricyclic PI3K inhibitor compounds and methods of use
#65Compounds and methods for IDO and TDO modulation, and indications therefor
#66Process for the manufacture of ixabepilone
#67Tricyclic PI3K inhibitor compounds and methods of use
#68Tricyclic compounds and uses thereof in medicine
#69Modified cytotoxins and their therapeutic use
#70AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS
#71Condensed heterocyclic compound
#72Oxaziridine compound and production method thereof
#73Salinosporamides and methods of use thereof
#74Substituted thiohydantoin derivatives as androgen receptor antagonists
#75Therapeutic isoxazole compounds
#76MTH1 inhibitors for treatment of cancer
#77Modified cytotoxins and their therapeutic use
#78Tetrahydrooxepinopyridine compound
#79Bicyclic lactams and methods of use thereof
#80Organic compound and organic electroluminescent element comprising same
#81PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#82RORγ modulators
#83Substituted oxepines
#84Fused piperidine amides as modulators of ion channels
#85Modulators of 5-HT receptors and methods of use thereof
#86Benzoxazepin PI3K inhibitor compounds and methods of use
#87Factor XIa inhibitors
#88Pyrrolo[2,3-d]pyrimidine derivatives
#89Aminoquinazoline derivatives and their salts and methods of use thereof
#90Chemokine receptor antagonists and methods of use
#91Pyrazolone derivatives as nitroxyl donors
#92Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
#93Therapeutic isoxazole compounds
#94LOW CATALYST LOADING IN METATHESIS REACTIONS
#95Salinosporamides and methods of use thereof
#96EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION
#97PARENTERAL FORMULATION FOR EPOTHILONE ANALOGS
#98PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#99Process for the preparation of asenapine maleate
#100EPOTHILONE DERIVATIVES
#101Compounds
#102ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE
#103CCR1 antagonists and methods of use thereof
#104CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
#105Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
#106Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
#107Pharmaceutical compounds
#108PROCESS FOR THE PREPARATION OF ASENAPINE INTERMEDIATE
#109Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#110COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#111Process for ixabepilone, and intermediates thereof
#112Compounds and compositions as c-kit kinase inhibitors
#113Salinosporamides and methods of use thereof
#114Heterocyclic nuclear hormone receptor modulators
#115Stable micronised monoclin form of asenapine maleate and its synthesis
#116Crystalline salts of Asenapine with organic di-acids and tri-acids
#117Crystalline asenapine hydrochloride salt forms
#118Crystalline salts of asenapine
#119Epothilone derivatives
#120CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR
#121PROCESS FOR THE PREPARATION OF TETRACYCLIC DERIVATIVES AND INTERMEDIATE PRODUCTS USED IN THE PROCESS
#122Material for organic electroluminescent elements, and organic electroluminescent element using same
#123Polymorphic forms of asenapine maleate and processes for their preparation
#124Process for the preparation of asenapine
#125Compounds, pharmaceutical compositions and uses thereof
#126MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS
#127Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
#128Compounds and compositions as c-Kit kinase inhibitors
#129Imidazo[1,2-a]pyridine derivative
#130Therapeutic isoxazole compounds
#131Sensitive and generic antibodies and multiple applications
#132Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
#133Epothilone compound formulations
#134Fused tricyclic aryl compounds useful for the treatment of viral diseases
#135Benzoxazepin PI3K inhibitor compounds and methods of use
#136Injectable formulations containing asenapine and method of treatment using same
#137Salinosporamides and methods for use thereof
#138Therapeutic isoxazole compounds
#139Processes for making epothilone compounds and analogs
#140Chemokine receptor antagonists and methods of use thereof
#141DEUTERIUM-ENRICHED IXABEPILONE
#142Compound, polymerizable composition, color filter, and method of producing the same, solid-state imaging device, and planographic printing plate precursor
#143CCR1 antagonists and methods of use therefor
#144Quaternary ammonium salt prodrugs
#145PROCESS FOR THE PREPARATION OF ASENAPINE AND INTERMEDIATE PRODUCTS USED IN SAID PROCESS
#146Asenapine Prodrugs
#147Macrocyclic compounds useful as pharmaceuticals
#148TETRACYCLIC COMPOUND
#149Heterocyclyl compounds
#150Benzoxazepin P13K inhibitor compounds and methods of use
#151QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS
#152Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor
#153Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
#154PROCESS IMPROVEMENT
#155Processes for making epothilone compounds and analogs
#156Modulators of 5-HT receptors and methods of use thereof
#157(E)-N-{3-[1-(8-fluoro-11H-10-OXA-1-AZA-dibenzo [A,D] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis
#158CCR1 antagonists and methods of use therefor
#159Process for the preparation of asenapine and intermediate products used in said process
#160Salinosporamides and methods for use thereof
#161Glucocorticoid receptor modulator and methods of use
#162Salinosporamides and methods for use thereof
#163Chemokine receptor antagonists and methods of use therefor
#164Epoxy compounds and method for production of the same
#165Trisubstituted 1,2,4-triazoles
#166(+)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE
#167(-)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE
#168Process for the preparation of asenapine and intermediate products used in said process
#169DEUTERIUM-ENRICHED ASENAPINE
#170Hepatitis C virus inhibitors
#171TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#172Calcilytic Compounds
#173Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
#174DEUTERIUM-ENRICHED IXABEPILONE
#175Parenteral formulation for epothilone analogs
#176HETEROCYCLODIAZEPINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE
#177Therapeutic isoxazole compounds
#178Analogs of salinosporamide A
#179Process for making asenapine
#180CCR1 antagonists and methods of use therefor
#181Process for the preparation of asenapine and intermediate products used in said process
#182Epothilone derivatives
#183Analogs of Salinosporamide A
#184Salinosporamides and methods for use thereof
#185Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
#186Chemokine receptor antagonists and methods of use therefor
#187Epothilone derivatives
#188Macrocyclic compounds useful as pharmaceuticals
#189Tricyclic steroid hormone nuclear receptor modulators
#190Parenteral formulation for epothilone analogs
#191CCR1 antagonists and methods of use therefor
#192Salinosporamides and methods for use thereof
#1932-benzo-[3,4-B]quinolino-[b,g]indeno[1′,2′:3,4]fluoreno-[1,2-d]oxonine-24-chloro-5,11,16,21-tetraone as an antimicrobial compound
#1942-benzo-[3,4-b]quinolino-[b,g]indeno[1,2:3,4]fluoreno-[1,2-d]oxonine-24-flouro-5,11,16,21-tetraone as an antimicrobial compound
#1952-benzo-[3,4-b]pyridine-[b,g]indeno[1,2;3,4]fluoreno-[1,2-d]oxonine-5,11,16,21-tetraone as an antimicrobial compound
#1962-benzo-[3,4-b] quinolino-{b,g]indeno [1′,2′:3,4] fluoreno-[1,2-d] Oxonine-5,11,16,21-tetraone as an antimicrobial compound
#197Antiviral heterocyclic compounds